1. Home
  2. ZLAB vs DHT Comparison

ZLAB vs DHT Comparison

Compare ZLAB & DHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • DHT
  • Stock Information
  • Founded
  • ZLAB 2013
  • DHT 2005
  • Country
  • ZLAB China
  • DHT Bermuda
  • Employees
  • ZLAB N/A
  • DHT N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • DHT Marine Transportation
  • Sector
  • ZLAB Health Care
  • DHT Consumer Discretionary
  • Exchange
  • ZLAB Nasdaq
  • DHT Nasdaq
  • Market Cap
  • ZLAB 3.6B
  • DHT 1.7B
  • IPO Year
  • ZLAB 2017
  • DHT 2005
  • Fundamental
  • Price
  • ZLAB $32.54
  • DHT $11.22
  • Analyst Decision
  • ZLAB Buy
  • DHT Strong Buy
  • Analyst Count
  • ZLAB 5
  • DHT 4
  • Target Price
  • ZLAB $54.28
  • DHT $13.75
  • AVG Volume (30 Days)
  • ZLAB 782.4K
  • DHT 1.8M
  • Earning Date
  • ZLAB 08-05-2025
  • DHT 08-11-2025
  • Dividend Yield
  • ZLAB N/A
  • DHT 8.61%
  • EPS Growth
  • ZLAB N/A
  • DHT 4.76
  • EPS
  • ZLAB N/A
  • DHT 1.10
  • Revenue
  • ZLAB $418,326,000.00
  • DHT $563,104,000.00
  • Revenue This Year
  • ZLAB $44.07
  • DHT N/A
  • Revenue Next Year
  • ZLAB $49.13
  • DHT $26.57
  • P/E Ratio
  • ZLAB N/A
  • DHT $10.19
  • Revenue Growth
  • ZLAB 43.72
  • DHT N/A
  • 52 Week Low
  • ZLAB $16.01
  • DHT $8.67
  • 52 Week High
  • ZLAB $44.34
  • DHT $12.32
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 40.19
  • DHT 49.32
  • Support Level
  • ZLAB $34.26
  • DHT $10.79
  • Resistance Level
  • ZLAB $35.72
  • DHT $11.45
  • Average True Range (ATR)
  • ZLAB 1.12
  • DHT 0.26
  • MACD
  • ZLAB -0.54
  • DHT -0.02
  • Stochastic Oscillator
  • ZLAB 3.83
  • DHT 34.59

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About DHT DHT Holdings Inc.

DHT Holdings Inc is a crude oil tanker company. Its fleet trades internationally and consists of crude oil tankers in the VLCC. The group generates revenues from time charter and spot market operations. It operates through integrated management companies in Monaco, Norway, Singapore, and India. The company generates the majority of its revenue from the shipping revenues.

Share on Social Networks: